Von Willebrand Disease (VWD)
Part 2: NHLBI Diagnosis Guidelines
Laboratory Recommendations
von Willebrand Disease Profile
June 2011
Based on our validation data, we developed this new VWD profile testing algorithm, as illustrated here.
von Willebrand Disease Profile |
Jump to section:
- Introduction
- Objectives
- History of VWF Ristocetin Cofactor Activity (VWF:RCo) Assay
- Problems with VWF:RCo Assay
- Summary of External Quality Assessment of VWF:RCo
- von Willebrand Disease(VWD) Diagnostic Error Rates Due to Erroneous VWF:RCo Results5
- VWF:RCo/Ag Ratio is Insensitive for Aquired von Willebrand Abnormalities (AVWA)
- VWF:RCo is Inadequate for Detecting AVW Abnormality
- The New Automated VWF Activity by Latex-Immunoturbidity Assay (VWF:Lx)
- VWF Activity Assay by an A1 Domain Conformation-Sensitive Antibody6
- Performance Characteristics of VWF:Lx
- VWF:Lx and VWF:RCo Method Comparison
- VWF:Lx and VWF:RCo Bias Analysis
- Sample Categorization
- Comparison of VWF:Lx/Ag and VWF:RCo/Ag Ratios
- VWF:Lx and VWF:RCo Errors
- Severe Type 1 vs 2M7
- VWF:Lx and RCo Errors
- VWF:Lx/Ag is Sensitive to AVWA with Subtle Loss of Highest HMWM
- ROC Analysis of VWF:Lx/Ag and VWF:RCo/Ag for Detecting AVWA with Loss of HMWMs
- VWF:Lx/Ag vs VWF:RCo/Ag Ratios
- VWF Laboratory Testing Strategy
- Sensitivity and Specificity of the Screening Panel
- von Willebrand Disease Profile
- von Willebrand Disease Profile
- von Willebrand Disease Profile
- von Willebrand Disease Profile
- Limitations of VWF:Lx
- Summary
- References
- Questions?
External
link
PDF
document
Excel
document
Word
document